Transcapital advises InVivo group on the divestiture of its subsidiary SAFE to Capital Croissance in collaboration with Unigrains, BNP PE and the management team.
InVivo, the leading French agricultural cooperative group with a turnover of €5.7bn for the financial year 2011/2012, mandated Transcapital to help it on its strategic refocusing by realizing the transfer of the company SAFE.
SAFE (formerly known under the brand UAR) is the indisputable French leader of the nutrition actvity for laboratory animals. With more than 400 customers (private and public laboratories, CRO, biotech…), SAFE holds approximately 60 % of the French market and realizes 20 % of its sales abroad. Based in Augy (Bourgogne), SAFE operates a modern industrial site, with ISO 9001 certification and an annual production capacity of 30,000 tons.
The company is the supplier of numerous major actors on its market such as: INRA, CNRS, Sanofi-Pasteur, Pierre and Marie Curie institute, Bayer, INSERM… Capital Croissance will be the new majority shareholder of SAFE alongside Unigrains, BNP Private Equity and the management team. InVivo will stay a business partner of SAFE for years to come.